Excellence in cancer research

Recruiting excellence in cancer research and precision medicine

The overall aim of this programme is to recruit internationally recognised senior faculty across various disciplines of cancer research and ultimately increase the critical mass in the area of cancer research at Barts and The London School of Medicine and Dentistry at Queen Mary University of London. This programme focusses on recruiting team leads in the three thematic areas of (1) Cancer prevention and risk reduction, (2) Screening and early diagnosis, and (3) Cancer genomics and evolution, and will provide the necessary infrastructure for these posts over a period of 3 years.

The themes (4) Targeting Tumour Cells and (5) Targeting the Tumour Stroma, that form the second part of this proposal were officially approved by the Charity in December 2017 and March 2018 respectively.

This programme will build upon and accelerate the international reputation of the Barts Cancer Centre (BCC).

The BCC receives infrastructural funding from Cancer Research UK (CRUK) as one of the Charity’s designated research centres, which supports core research facilities within the building (for example microscopy and animal facilities), as well as providing studentships and other financial support for research. The CRUK- BCC funding is based around the five key research themes listed above, that each represent areas of broad research excellence within the institute.

The programme combines skills, abilities, experience and expertise that are specific only to SMD. It will help to build a unique interdisciplinary environment with translational research at its core delivering, wide-ranging and ambitious goals for the benefit of many hundreds of patients within Barts Health NHS Trust and the wider community in the short term and many thousands of patients in the long-term.

Cancer genomics and evolution at Barts Cancer Institute